Genomics and synthetic biology are reshaping healthcare, as rapid DNA sequencing advances power personalized medicine and ...

An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...

Genomics’ fourth quarter results saw stable revenue performance despite a subdued research funding environment, with management crediting continued consumables growth and increased adoption of new ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 10.5% in the morning session after the company reported better-than-expected fourth-quarter results, highlighted by a smaller loss than ...

Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...

Wave Life Sciences Ltd. (NASDAQ:WVE) is among the Best Genomics Stocks. TheFly reports that on December 19, 2025, H.C. Wainwright upgraded Wave Life Sciences Ltd. (NASDAQ:WVE)’s price target from $22 ...

Genomics (TXG) reported $166.03 million in revenue for the quarter ended December 2025, representing a year-over-year ...

Full-year instruments revenue fell 39% year-over-year while consumables grew 3%, highlighting a key challenge as the company navigates a strategic product transition. Wall Street expects a ...

LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

Tempus AI, Inc. (NASDAQ:TEM) is among the Best Genomics Stocks. TheFly reported on December 22, 2025, that Canaccord reduced the price objective for Tempus AI, Inc. (NASDAQ:TEM) to $80 from $95. The ...